12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Thursday's intraday session, several healthcare stocks experienced significant movements. Gainers included Caribou Biosciences (CRBU), Aethlon Medical (AEMD), Incannex Healthcare (IXHL), Myomo (MYO), Kintara Therapeutics (KTRA), and C4 Therapeutics (CCCC). Losers included Allarity Therapeutics (ALLR), Trinity Biotech (TRIB), ASLAN Pharma (ASLN), Nymox Pharmaceutical (NYMX), ALX Oncology Holdings (ALXO), and Comera Life Sciences (CMRA).
July 06, 2023 | 5:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aethlon Medical stock moved upwards by 26.08% to $0.43. The stock is trading at a volume of 6.0 million shares, which is 647.1% of its average full-day volume over the last 100 days.
The significant increase in Aethlon Medical's stock price and trading volume suggests a positive market sentiment towards the company, which could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Caribou Biosciences stock rose 50.7% to $6.15 during Thursday's session. The current volume of 75.4 million shares is 9750.6% of its average full-day volume over the last 100 days.
The significant increase in Caribou Biosciences' stock price and trading volume suggests a positive market sentiment towards the company, which could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Allarity Therapeutics shares fell 54.1% to $3.8 during Thursday's session. Trading volume for this security is 2.5 million, which is 868.6% of its average full-day volume over the last 100 days.
The significant decrease in Allarity Therapeutics' stock price and increase in trading volume suggests a negative market sentiment towards the company, which could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Trinity Biotech shares decreased by 27.07% to $0.78. The stock is trading at a volume of 585.7K shares, which is 1442.8% of its average full-day volume over the last 100 days.
The significant decrease in Trinity Biotech's stock price and increase in trading volume suggests a negative market sentiment towards the company, which could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100